Manuel; Edwin

Patent Applications and Registrations

Patent applications and USPTO patent grants for Manuel; Edwin.The latest application filed is for "anticancer combinations".

Company Profile

2.5.6

Manuel; Edwin - Pomona CA
Manuel; Edwin - San Diego CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Anticancer Combinations App 20220241432 - Diamond; Don J. ; et al.	2022-08-04
Anticancer combinations Grant 11,141,492 - Diamond , et al. October 12, 2	2021-10-12
Tumor associated vaccines and compositions for disrupting tumor-derived immunosuppression for use in combination cancer immunotherapy Grant 10,961,538 - Diamond , et al. March 30, 2	2021-03-30
Tumor Associated Vaccines And Compositions For Disrupting Tumor-derived Immunosuppression For Use In Combination Cancer Immunoth App 20200157549 - DIAMOND; Don J. ; et al.	2020-05-21
Tumor associated vaccines and compositions for disrupting tumor-derived immunosuppression for use in combination cancer immunotherapy Grant 10,584,339 - Diamond , et al.	2020-03-10
Tumor Associated Vaccines And Compositions For Disrupting Tumor-derived Immunosuppression For Use In Combination Cancer Immunoth App 20190153452 - Diamond; Don J. ; et al.	2019-05-23
Tumor associated vaccines and compositions for disrupting tumor-derived immunosuppression for use in combination cancer immunotherapy Grant 10,100,314 - Diamond , et al. October 16, 2	2018-10-16
Tumor Associated Vaccines And Compositions For Disrupting Tumor-derived Immunosuppression For Use In Combination Cancer Immunotherapy App 20170081671 - DIAMOND; Don J. ; et al.	2017-03-23
Tumor associated vaccines and compositions for disrupting tumor-derived immunosuppression for use in combination cancer immunotherapy Grant 9,453,227 - Diamond , et al. September 27, 2	2016-09-27
Anticancer Combinations App 20160184456 - Diamond; Don J. ; et al.	2016-06-30
Tumor Associated Vaccines And Compositions For Disrupting Tumor-derived Immunosuppression For Use In Combination Cancer Immunotherapy App 20140186401 - Diamond; Don J. ; et al.	2014-07-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.